Literature DB >> 21910169

Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.

M Zilbauer1, A Jenke, G Wenzel, D Goedde, J Postberg, A D Phillips, M Lucas, G Noble-Jamieson, F Torrente, C Salvestrini, R Heuschkel, S Wirth.   

Abstract

BACKGROUND: Reduced alpha-defensin expression has been reported in the terminal ileum (TI) of adult patients with ileal Crohn's disease (CD). However, little is known about alpha-defensin expression in children with chronic inflammatory bowel disease (IBD).
METHODS: In all, 283 intestinal biopsies were obtained from children with CD, ulcerative colitis (UC), and healthy controls. Absolute mRNA copy numbers for HD5, HD6, IL-8, Villin 1, and Tcf-4 were analyzed by reverse-transcription polymerase chain reaction (RT-PCR). HD5 immunostaining was performed on biopsy sections and patients genotyped for NOD2 mutations.
RESULTS: Equal expression levels of alpha-defensins (HD5 and HD6) were found in TI biopsies of children with ileal CD (L1+L3) compared to patients with colonic disease (L2) and healthy controls. In contrast, we found significantly higher levels of alpha-defensins in the TI of children with UC compared to CD and controls. Reduced expression of Tcf-4 was observed exclusively in the duodenum and TI of CD patients with L1+L3 phenotype. We demonstrate significantly increased expression of HD5 and HD6 in the inflamed colon of IBD children (UC and CD) attributable to the presence of metaplastic Paneth cells.
CONCLUSIONS: In this study no difference in alpha-defensin expression was found in the TI of CD children and controls. However, significant reduction of Tcf-4 in L1+L3 phenotype suggests that a possibly impaired PC differentiation may lead to altered HD5 and HD6 expression at some stage of disease. Additionally, substantially increased expression of alpha-defensins in the inflamed colonic mucosa of children with IBD raises the question for their potential involvement in modulating inflammation in these patients.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21910169     DOI: 10.1002/ibd.21577

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  11 in total

Review 1.  The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases.

Authors:  Richard H Siggers; David J Hackam
Journal:  Cell Mol Life Sci       Date:  2011-10-11       Impact factor: 9.261

2.  Effect of bifidobacterium on defensin-5 expression in intestinal injury of preweaning rats.

Authors:  Wei Wang; Shu-Fen Yang; Li-Hong Ren; Xiu-Xiu Zhang; Shui-Lian Yu
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

3.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Recombinant human beta 2-defensin fusion proteins as a tool to investigate defensin structure and function in small human intestinal tissue samples.

Authors:  Annekatrin Coordes; Andreas Andreou; Ulrike Erben; Thorsten Stroh; Katja Blunert; Nadia Slavova; Britta Siegmund; Heinz-Johannes Buhr; Anton J Kroesen
Journal:  Inflamm Res       Date:  2012-08-26       Impact factor: 4.575

Review 5.  An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease.

Authors:  Jan Wehkamp; Eduard F Stange
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

6.  Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes.

Authors:  Bas Kremer; Rob Mariman; Marjan van Erk; Tonny Lagerweij; Lex Nagelkerken
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 7.  Antimicrobial peptides and gut microbiota in homeostasis and pathology.

Authors:  Maureen J Ostaff; Eduard Friedrich Stange; Jan Wehkamp
Journal:  EMBO Mol Med       Date:  2013-08-23       Impact factor: 12.137

8.  Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen.

Authors:  Hongye Fan; Guanjun Dong; Guangfeng Zhao; Fei Liu; Genghong Yao; Yichao Zhu; Yayi Hou
Journal:  J Immunol Res       Date:  2014-02-13       Impact factor: 4.818

9.  Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5.

Authors:  Jenny-Lee Thomassin; Mark J Lee; John R Brannon; Donald C Sheppard; Samantha Gruenheid; Hervé Le Moual
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

10.  Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children.

Authors:  Naomi Simmonds; Mark Furman; Evi Karanika; Alan Phillips; Alan W H Bates
Journal:  BMC Gastroenterol       Date:  2014-05-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.